Disc Medicine (IRON) Amortization of Deferred Charges (2024 - 2026)

Disc Medicine's (IRON) quarterly Amortization of Deferred Charges came in at $206000.0 in Q1 2026, little changed year-on-year from $207000.0 in Q1 2025, and down 2.37% on a QoQ basis from $211000.0 in Q4 2025.

Disc Medicine (IRON) Amortization of Deferred Charges (2024 - 2026) Analysis & Trends

Disc Medicine (IRON) has 3 years of Amortization of Deferred Charges data on file, last reported at $206000.0 in Q1 2026.

  • On a quarterly basis, Amortization of Deferred Charges changed 0.48% year-over-year to $206000.0 in Q1 2026; TTM through Mar 2026 was $836000.0, a 150.3% increase from a year earlier, with the FY2025 full-year figure at $837000.0, up 559.06% from the prior year.
  • Amortization of Deferred Charges for Q1 2026 stood at $206000.0, down from $211000.0 in the prior quarter.
  • Over the last five years, Amortization of Deferred Charges for IRON reached as high as $211000.0 in Q3 2025 and fell as low as $127000.0 in Q4 2024.
  • Historically, Amortization of Deferred Charges has averaged $195000.0 across 3 years, with a median of $207500.0 in 2025.
  • Across the five-year window, Amortization of Deferred Charges soared 66.14% in 2025 and dropped 0.48% in 2026, its largest moves.
  • Year by year, Amortization of Deferred Charges stood at $127000.0 in 2024, then soared by 66.14% to $211000.0 in 2025, then decreased by 2.37% to $206000.0 in 2026.
  • Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $206000.0 in Q1 2026, $211000.0 in Q4 2025, and $211000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 65,538.84 Bn 65,538.56 Bn -
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn -
4 BeOne Medicines 469.46 Bn 464.67 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.69 Bn 115.45 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.41 Bn 61.65 Bn 3.31 Bn
7 Belite Bio 62.84 Bn 62.84 Bn -
8 Argenx Se 56.10 Bn 50.91 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.48 Bn 34.47 Bn 959.66 Mn
10 Disc Medicine 2.88 Bn 2.88 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 206,000.00
Mar 31, 2026 206,000.00
Dec 31, 2025 211,000.00
Dec 31, 2025 211,000.00
Sep 30, 2025 211,000.00
Sep 30, 2025 211,000.00
Jun 30, 2025 208,000.00
Jun 30, 2025 208,000.00
Mar 31, 2025 207,000.00
Mar 31, 2025 207,000.00
Dec 31, 2024 127,000.00
Dec 31, 2024 127,000.00